10
de Joode, K., Dumoulin, D., Tol, J., Westgeest, H., Beerepoot, L., Van den Berkmortel, F., Mutsaers, P., van Diemen, N., Visser, O., Bloemendal, H. J., van Laarhoven, H., Hendriks, L., Haanen, J. B. A. G., de Vries, E. G. E., Dingemans, A-M. C., Van der Veldt, A.
Veröffentlicht in: D Dutch Oncology COVID-19 , de Joode , K , Dumoulin , D , Tol , J , Westgeest , H , Beerepoot , L , Van den Berkmortel , F , Mutsaers , P , van Diemen , N , Visser , O , Bloemendal , H J , van Laarhoven , H , Hendriks , L , Haanen , J B A G , de Vries , E G E , Dingemans , A-M C & Van der Veldt , A 2020 , ' Dutch oncology COVID-19 Consortium (DOCC) : Outcome of COVID-19 in patients with cancer in a nationwide cohort study ' , Annals of Oncology , vol. 31 , pp. S1207-S1208 . https://doi.org/10.1016/j.annonc.2020.08.2320 ; ISSN:0923-7534;
2020